Jump to content

Search the hub

Showing results for tags 'Medicine - Neurology'.

More search options

  • Search By Tags

    Start to type the tag you want to use, then select from the list.

  • Search By Author

Content Type


Forums

  • All
    • Commissioning, service provision and innovation in health and care
    • Coronavirus (COVID-19)
    • Culture
    • Improving patient safety
    • Investigations, risk management and legal issues
    • Leadership for patient safety
    • Organisations linked to patient safety (UK and beyond)
    • Patient engagement
    • Patient safety in health and care
    • Patient Safety Learning
    • Professionalising patient safety
    • Research, data and insight
    • Miscellaneous

Categories

  • Commissioning, service provision and innovation in health and care
    • Commissioning and funding patient safety
    • Digital health and care service provision
    • Health records and plans
    • Innovation programmes in health and care
    • Climate change/sustainability
  • Coronavirus (COVID-19)
    • Blogs
    • Data, research and statistics
    • Frontline insights during the pandemic
    • Good practice and useful resources
    • Guidance
    • Mental health
    • Exit strategies
    • Patient recovery
  • Culture
    • Bullying and fear
    • Good practice
    • Occupational health and safety
    • Safety culture programmes
    • Second victim
    • Speak Up Guardians
    • Staff safety
    • Whistle blowing
  • Improving patient safety
    • Clinical governance and audits
    • Design for safety
    • Disasters averted/near misses
    • Equipment and facilities
    • Error traps
    • Health inequalities
    • Human factors (improving human performance in care delivery)
    • Improving systems of care
    • Implementation of improvements
    • International development and humanitarian
    • Safety stories
    • Stories from the front line
    • Workforce and resources
  • Investigations, risk management and legal issues
    • Investigations and complaints
    • Risk management and legal issues
  • Leadership for patient safety
    • Business case for patient safety
    • Boards
    • Clinical leadership
    • Exec teams
    • Inquiries
    • International reports
    • National/Governmental
    • Patient Safety Commissioner
    • Quality and safety reports
    • Techniques
    • Other
  • Organisations linked to patient safety (UK and beyond)
    • Government and ALB direction and guidance
    • International patient safety
    • Regulators and their regulations
  • Patient engagement
    • Consent and privacy
    • Harmed care patient pathways/post-incident pathways
    • How to engage for patient safety
    • Keeping patients safe
    • Patient-centred care
    • Patient stories
  • Patient safety in health and care
    • Care settings
    • Conditions
    • Diagnosis
    • High risk areas
    • Learning disabilities
    • Medication
    • Mental health
    • Men's health
    • Patient management
    • Social care
    • Transitions of care
    • Women's health
  • Patient Safety Learning
    • Patient Safety Learning campaigns
    • Patient Safety Learning documents
    • Patient Safety Learning news archive
    • 2-minute Tuesdays
    • Patient Safety Learning Annual Conference 2019
    • Patient Safety Learning Annual Conference 2018
    • Patient Safety Learning Awards 2019
    • Patient Safety Learning Interviews
    • Patient Safety Learning webinars
  • Professionalising patient safety
    • Accreditation for patient safety
    • Competency framework
    • Medical students
    • Patient safety standards
    • Training
  • Research, data and insight
    • Data and insight
    • Research
  • Miscellaneous

News

  • News

Find results in...

Find results that contain...


Date Created

  • Start
    End

Last updated

  • Start
    End

Filter by number of...

Joined

  • Start

    End

Group

First name

Last name

Country

Join a private group (if appropriate)

About me

Organisation

Role

Found 38 results
  1. Content Article
  2. News Article
    Elon Musk's attempt to implant microchips into human brains has been rejected by US medical regulators over concerns about the safety of the technology. Mr Musk's Neuralink business, which is hoping to insert tiny chips into people's skulls to treat conditions such as paralysis and blindness, was denied initial permission for clinical trials last year. US medical regulators were said to have "dozens" of concerns over the risks posed by the device, Reuters reported. Concerns include fears that tiny electrodes could get lodged in other parts of the brain, which could impair cognitive function or rupture blood vessels. Neuralink's chips are designed to be threaded into the brain using tiny filaments and harness artificial intelligence technology to pick up brain activity using a so-called "brain computer interface". Read full story (paywalled) Source: The Times, 3 March 2023
  3. Content Article
    The report identified: Poor practice including a lack of proper clinical investigation. Inaccurate diagnosis. Poor prescribing practices. Poor record keeping. Lack of openness and effective communication. Inappropriate treatment The risks of clinicians working in isolation. The expert panel has made specific recommendations for RQIA including: Ensuring that patients have direct access to doctors’ letters. Ensuring proper multidisciplinary team working. Tackling isolation in clinicians working alone. These important recommendations are at the heart of addressing the failings of the care and treatment provided. Clinicians must be supported to adopt good practice, especially in using up to date best practice routes to diagnosis and treatments. They should be encouraged and facilitated to seek the support of peers and others to challenge and review their analysis and thinking. These are issues, not only for neurology services, but throughout the health and social care system.
  4. News Article
    A review of the clinical records of 44 patients who died under the care of former neurologist Michael Watt has found "significant failures in their treatment" and "poor communication with families". While this review looked at a sample of cases in which people died, potentially thousands more could be affected. The review arises from a 2018 recall of 2,500 outpatients who were in Dr Watt's care at the Belfast Health Trust. About one in five patients had to have their diagnoses changed. This separate review into 44 deaths was conducted by the Royal College of Physicians at the request of the regulator, the Regulation and Quality Improvement Authority (RQIA). It highlighted concerns over clinical decision-making, prescribing and diagnostics. It reveals a misdiagnosis rate of 45% among this group of patients, twice that for living patients. Speaking to BBC News NI, the RQIA's chair, Christine Collins, said the outcome of the review was "shocking and gut-wrenching as so many had experienced unpleasant deaths which they ought not to have done". Read full story Source: BBC News, 29 November 2022
  5. Content Article
  6. News Article
    Two years after having Covid-19, diagnoses of brain fog, dementia and epilepsy are more common than after other respiratory infections, a study by the University of Oxford suggests. But anxiety and depression are no more likely in adults or children two years on, the research found. More research is needed to understand how and why Covid could lead to other conditions. This study looked at the risks of 14 different disorders in 1.25 million patients two years on from Covid, mostly in the US. It then compared them with a closely-matched group of 1.25 million people who had a different respiratory infection. In the group who had Covid, after two years, there were more new cases of: dementia, stroke and brain fog in adults aged over 65 brain fog in adults aged 18-64 epilepsy and psychotic disorders in children, although the overall risks were small. Some disorders became less common two years after Covid, including: anxiety and depression in children and adults psychotic disorders in adults. The increased risk of depression and anxiety in adults lasts less than two months before returning to normal levels, the research found. Read full story Source BBC News, 18 August 2022
  7. Content Article
  8. News Article
    Systems and processes in place around patient safety failed in terms of the work of a Belfast-based neurologist, an inquiry has found. Dr Michael Watt was at the centre of Northern Ireland’s largest ever recall of patients, which began in 2018, after concerns were raised about his clinical work. More than 4,000 of his former patients attended recall appointments. Almost a fifth of patients who attended recall appointments were found to have received an “insecure diagnosis”. The final report following the Independent Neurology Inquiry found that problems with Dr Watt’s practice were missed for years and opportunities to intervene were lost. It makes 76 recommendations to the Department of Health, healthcare organisations, General Medical Council and the independent sector. “While one process or system failure may not be critical, the synergistic effect of numerous failures ensured that a problem with an individual doctor’s practice was missed for many years and, as this inquiry finds, opportunities to intervene, particularly in 2006/2007, 2012/2013, and earlier in 2016 were lost,” the inquiry found. Read full story Source: The Independent, 21 June 2022
  9. Content Article
    Call for action The report calls on the UK Government, Scottish Government, Welsh Government and Northern Ireland Executive to prioritise services for people with neurological conditions and establish a Neuro Taskforce. The Taskforce would bring together relevant departments, health and social care bodies, professional bodies, people affected by neurological conditions and the voluntary sector to: Assess the current neuroscience workforce and set out plans to ensure it is fit for the future. Share approaches to common problems, such as addressing longstanding barriers to accessing mental, emotional and cognitive support, driving down waiting lists for elective care, improving the quality and analysis of health and care data and supporting transition between paediatric and adult neuroscience services. Assess the level of investment in research into the causes, impacts and possible cures of neurological conditions and set out plans to level up investment in areas that do not receive a fair share currently.
  10. Content Article
    Key conclusions include: The Belfast Trust should have intervened earlier, but failed to do so. Systems and processes in place to assure the public about patient safety prior to November 2016 failed. The effect of numerous failures ensured problems were missed for many years and opportunities to intervene were lost. Failures not confined to Belfast Trust - information was contained in silos with communications between different organisations and management levels poor and inadequate.
  11. Content Article
    The toolkit covers the following neurological conditions: multiple sclerosis (MS) motor neurone disease (MND) Parkinson’s and the atypical Parkinsonism’s of multiple system atrophy (MSA) progressive supranuclear palsy (PSP) corticobasal degeneration (CBD).
  12. Content Article
    The guidelines offer updated guidance on the diagnosis, assessment, care and management of patients with PDOC. They support doctors, families and health service commissioners to ensure that everyone is aware of their legal and ethical responsibilities. The guidelines cover: Definitions and terminology of PDOC. Techniques for assessment, diagnosis and review. Care pathways from acute to long-term management. The ethical and medico-legal framework for decision-making. Practical decision-making regarding starting or continuing life-sustaining treatments, including CANH, and management of end-of-life care for PDOC patients. Service organisation and commissioning.
  13. Content Article
  14. Content Article
  15. Content Article
    The Healthcare Safety Investigation Branch (HSIB) published ‘Summary of themes arising from the Healthcare Safety Investigation Branch maternity programme (April 2018-December 2019)’ in February 2020. This described eight themes for further exploration in order to highlight opportunities for system-wide learning; one of these themes was group B streptococcus (GBS). This report, Severe brain injury, early neonatal death and intrapartum stillbirth associated with group B streptococcus infection, highlights a number of patient safety concerns and recommends that maternity care providers should consider the findings and make necessary changes to their local systems to ensure that mothers and babies receive care in line with national guidance. The Healthcare Safety Investigation Branch will keep the theme of group B streptococcus under review and consider a future national investigation to explore this subject further.
  16. Content Article
  17. Content Article
  18. Content Article
  19. Content Article
  20. Content Article
  21. Content Article
  22. Content Article
  23. News Article
    Suspended Belfast neurologist Michael Watt has offered his "sincere sympathy" to those affected by Northern Ireland's biggest patient recall. Dr Michael Watt worked at the Royal Victoria Hospital as a neurologist diagnosing conditions like epilepsy and Parkinson's Disease. He was suspended after 3,000 patients were given recall appointments last year. Dr Watt said he recognised the "distress these events have caused". On Tuesday, a BBC Spotlight investigation found that he had carried out hundreds of unnecessary procedures on patients. The programme also obtained details of a Department of Health report, as yet unpublished, that said one-in-five patients of the consultant neurologist were misdiagnosed. Read full story Source: BBC News, 22 November 2019
  24. Event
    until
    This webinar is organised by the Fellowship of Postgraduate Medicine. The panel will review the neurological and neuropsychiatric sequelae of COVID-19, what is known about this emerging spectrum of disorders, It is timely to review what we know and don’t know about the neurological and neuropsychiatric sequelae of COVID-19, what is known about why they happen and what treatments to consider. Register
  25. News Article
    An NHS trust has been urged to publish the full findings of an independent review of its services after it released a heavily redacted report. University Hospitals Sussex has refused to reveal the recommendations made after a review by the Royal College of Surgeons in 2019. A patients' group said the findings should be "in the public domain". The trust said the review of its neurosurgery department "did not highlight any safety concerns". The review was discovered as part of a BBC Panorama investigation into unpublished patient safety reports. A heavily edited report was released under freedom of information laws. It showed the trust asked the Royal College of Surgeons to look at "concerns raised in respect of clinical outcomes, allocation of sub-specialties and governance arrangements". All issues and recommendations were obscured, with only positive feedback disclosed. Read full story Source: BBC News, 20 May 2021
×